55 University Ave.
Suite 1003
Toronto, ON M5J 2H7
Canada
https://www.fsdpharma.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Zeeshan Saeed | Founder, CEO, President & Executive Co-Chairman | 222.62k | N/A | 1970 |
Mr. Anthony John Durkacz | Founder & Executive Co-Chairman | 222.62k | N/A | 1976 |
Mr. Nathan Coyle CPA | Chief Financial Officer | 178.21k | N/A | 1981 |
Mr. Donal Carroll CPA | Chief Operating Officer | 225.62k | N/A | 1977 |
Dr. Lakshmi P. Kotra BPHARM, Ph.D. | CEO of Lucid & Director | 144.72k | N/A | 1971 |
Ms. Maryann Adesso | Corporate Secretary | N/A | N/A | N/A |
Randell Mack | President of FSD BioSciences | N/A | N/A | N/A |
Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs of Lucid | 110.3k | N/A | N/A |
Mr. Kevin Cassidy | Vice President of Quality-Lucid | 144.82k | N/A | N/A |
FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.
FSD Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.